About Noninvasix

About company

Using patented optoacoustic technology, the experienced team of life science innovators and medical engineers at Noninvasix, Inc. have developed an elegant solution for the safe, accurate and non-invasive monitoring of fetal welfare during labor and delivery. In collaboration with obstetricians at University of Texas Medical Branch at Galveston, Noninvasix designed a small fetal probe which emits light pulses resulting in an acoustic wave response which accurately measures the baby's brain oxygenation levels. In addition to the reduced incidence of unnecessary cesarean sections, this first-in-class optoacoustic monitoring technology is expected to reduce the risk of severe neonatal morbidity including cerebral palsy. Noninvasix's undertaking to significantly improve outcomes for mother and child during labor and reduce malpractice lawsuits and premiums is backed by 15 years of optoacoustic research by its co-founders, more than $6.5 million in research grants and validation in peer-review journal articles.